These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

110 related items for PubMed ID: 2741341

  • 1. Influenza A (H1N1) vaccine efficacy in animal models is influenced by two amino acid substitutions in the hemagglutinin molecule.
    Wood JM, Oxford JS, Dunleavy U, Newman RW, Major D, Robertson JS.
    Virology; 1989 Jul; 171(1):214-21. PubMed ID: 2741341
    [Abstract] [Full Text] [Related]

  • 2. Selection of a single amino acid substitution in the hemagglutinin molecule by chicken eggs can render influenza A virus (H3) candidate vaccine ineffective.
    Kodihalli S, Justewicz DM, Gubareva LV, Webster RG.
    J Virol; 1995 Aug; 69(8):4888-97. PubMed ID: 7609057
    [Abstract] [Full Text] [Related]

  • 3. Immune response of human volunteers and animals to vaccination with egg-grown influenza A (H1N1) virus is influenced by three amino acid substitutions in the haemagglutinin molecule.
    Newman RW, Jennings R, Major DL, Robertson JS, Jenkins R, Potter CW, Burnett I, Jewes L, Anders M, Jackson D.
    Vaccine; 1993 Aug; 11(4):400-6. PubMed ID: 8470424
    [Abstract] [Full Text] [Related]

  • 4. Efficacy of inactivated influenza A virus (H3N2) vaccines grown in mammalian cells or embryonated eggs.
    Katz JM, Webster RG.
    J Infect Dis; 1989 Aug; 160(2):191-8. PubMed ID: 2760480
    [Abstract] [Full Text] [Related]

  • 5. Host cell-mediated variation in H3N2 influenza viruses.
    Katz JM, Naeve CW, Webster RG.
    Virology; 1987 Feb; 156(2):386-95. PubMed ID: 3811239
    [Abstract] [Full Text] [Related]

  • 6. Evaluation of immune responses to inactivated influenza vaccines prepared in embryonated chicken eggs and MDCK cells in a mouse model.
    Nerome K, Kumihashi H, Nerome R, Hiromoto Y, Yokota Y, Ueda R, Omoe K, Chiba M.
    Dev Biol Stand; 1999 Feb; 98():53-63; discussion 73-4. PubMed ID: 10494959
    [Abstract] [Full Text] [Related]

  • 7. Antigenic and structural characterization of multiple subpopulations of H3N2 influenza virus from an individual.
    Katz JM, Webster RG.
    Virology; 1988 Aug; 165(2):446-56. PubMed ID: 3407150
    [Abstract] [Full Text] [Related]

  • 8. Protective efficacy of intranasal cold-adapted influenza A/New Caledonia/20/99 (H1N1) vaccines comprised of egg- or cell culture-derived reassortants.
    Palker T, Kiseleva I, Johnston K, Su Q, Toner T, Szymkowiak C, Kwan WS, Rubin B, Petrukhin L, Wlochowski J, Monteiro J, Kraiouchkine N, DiStefano D, Rudenko L, Shaw A, Youil R.
    Virus Res; 2004 Oct; 105(2):183-94. PubMed ID: 15351492
    [Abstract] [Full Text] [Related]

  • 9. Growth and immunogenicity of influenza viruses cultivated in Vero or MDCK cells and in embryonated chicken eggs.
    Govorkova EA, Kodihalli S, Alymova IV, Fanget B, Webster RG.
    Dev Biol Stand; 1999 Oct; 98():39-51; discussion 73-4. PubMed ID: 10494958
    [Abstract] [Full Text] [Related]

  • 10. Immunogenicity and protective efficacy in mice of influenza B virus vaccines grown in mammalian cells or embryonated chicken eggs.
    Alymova IV, Kodihalli S, Govorkova EA, Fanget B, Gerdil C, Webster RG.
    J Virol; 1998 May; 72(5):4472-7. PubMed ID: 9557744
    [Abstract] [Full Text] [Related]

  • 11. Amino acid sequence identity between the HA1 of influenza A (H3N2) viruses grown in mammalian and primary chick kidney cells.
    Katz JM, Webster RG.
    J Gen Virol; 1992 May; 73 ( Pt 5)():1159-65. PubMed ID: 1588320
    [Abstract] [Full Text] [Related]

  • 12. [Immune protective effectiveness of seasonal influenza spilt vaccine against homologous and heterogonous subtypes of influenza virus in mice].
    Huang BY, Wang XP, Wang WL, Hu W, Gao Q, Tan WJ, Ruan L.
    Bing Du Xue Bao; 2011 May; 27(3):265-73. PubMed ID: 21774253
    [Abstract] [Full Text] [Related]

  • 13. Direct isolation in eggs of influenza A (H1N1) and B viruses with haemagglutinins of different antigenic and amino acid composition.
    Oxford JS, Newman R, Corcoran T, Bootman J, Major D, Yates P, Robertson J, Schild GC.
    J Gen Virol; 1991 Jan; 72 ( Pt 1)():185-9. PubMed ID: 1990062
    [Abstract] [Full Text] [Related]

  • 14. Structural changes in the haemagglutinin which accompany egg adaptation of an influenza A(H1N1) virus.
    Robertson JS, Bootman JS, Newman R, Oxford JS, Daniels RS, Webster RG, Schild GC.
    Virology; 1987 Sep; 160(1):31-7. PubMed ID: 3629978
    [Abstract] [Full Text] [Related]

  • 15. Influence of host cell-mediated variation on the international surveillance of influenza A (H3N2) viruses.
    Meyer WJ, Wood JM, Major D, Robertson JS, Webster RG, Katz JM.
    Virology; 1993 Sep; 196(1):130-7. PubMed ID: 8356790
    [Abstract] [Full Text] [Related]

  • 16. Safety and immunogenicity of a recombinant protein influenza A vaccine in adult human volunteers and protective efficacy against wild-type H1N1 virus challenge.
    Fries LF, Dillon SB, Hildreth JE, Karron RA, Funkhouser AW, Friedman CJ, Jones CS, Culleton VG, Clements ML.
    J Infect Dis; 1993 Mar; 167(3):593-601. PubMed ID: 8440931
    [Abstract] [Full Text] [Related]

  • 17. Efficacy of A/H1N1/2009 split inactivated influenza A vaccine (GC1115) in mice and ferrets.
    Han HJ, Song MS, Park SJ, Byun HY, Robles NJC, Ha SH, Choi YK.
    J Microbiol; 2019 Feb; 57(2):163-169. PubMed ID: 30706345
    [Abstract] [Full Text] [Related]

  • 18. The impact of key amino acid substitutions in the hemagglutinin of influenza A (H3N2) viruses on vaccine production and antibody response.
    Chen Z, Zhou H, Jin H.
    Vaccine; 2010 May 28; 28(24):4079-85. PubMed ID: 20399830
    [Abstract] [Full Text] [Related]

  • 19. Neuraminidase-Inhibiting Antibody Titers Correlate with Protection from Heterologous Influenza Virus Strains of the Same Neuraminidase Subtype.
    Walz L, Kays SK, Zimmer G, von Messling V.
    J Virol; 2018 Sep 01; 92(17):. PubMed ID: 29925654
    [Abstract] [Full Text] [Related]

  • 20. Cross-protection against influenza A virus infection by passively transferred respiratory tract IgA antibodies to different hemagglutinin molecules.
    Tamura S, Funato H, Hirabayashi Y, Suzuki Y, Nagamine T, Aizawa C, Kurata T.
    Eur J Immunol; 1991 Jun 01; 21(6):1337-44. PubMed ID: 1646112
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.